Anti-malarial Drug
- All
- News
- Videos
-
Over 1 Crore PPEs, 10 Crore Anti-Malarial Drug HCQ Distributed To States Free Of Cost: Government
Over 3.04 crore N95 masks, more than 1.28 crore PPE kits and over 10.83 crore HCQ tablets have been distributed among the states, union territories and central institutions, free of cost by the central government since March 11, said the Union Ministry of Health and Family Welfare on Thursday.
-
Centre Lifts Export Ban On Anti-Malarial Drug Hydroxychloroquine
The government on Thursday lifted the export ban on anti-malarial drug hydroxychloroquine with immediate effect.
-
Anti-Malarial Drug HCQ Does Not Reduce COVID-19 Mortality Rate, Says WHO, Halts Trial
The World Health Organization said it had decided Wednesday to halt trials of hydroxychloroquine as a potential treatment for COVID-19 patients, finding it did not reduce the mortality rate.
-
US Revokes Emergency Use Status Of Anti-Malarial Drug HCQ In COVID-19 Treatment
The United States on Monday withdrew emergency use authorizations for two coronavirus treatments favored by President Donald Trump, citing their lack of efficacy and safety concerns.
-
Health Ministry Okays Anti-Malarial Drug HCQ For Early Course Of COVID-19
The Union Health Ministry has recommended use of anti-viral drug remdesivir under emergency use authorization, off-label application of immunomodulator tocilizumab and convalescent plasma therapy for treating COVID-19 patients in moderate stage of criticality.
-
India Lifts Export Ban On Trump-Touted COVID-19 Drug Hydroxychloroquine
India has lifted an export ban on hydroxychloroquine, the anti-malarial drug touted by US President Donald Trump as a potential "game changer" in the fight against the COVID-19 pandemic, a minister said late on Wednesday.
-
Medical Journal Lancet Withdraws Study Flagging COVID-19 Drug's Risk
Three of the four authors behind a large-scale study in The Lancet that raised safety fears over the use of common anti-malarial drugs to treat COVID-19 retracted their paper on Thursday, blaming a health care company that supplied the dataset.
-
Anti-Malarial Drug, PPEs Prevented COVID-19 Among Health Workers: Report
Sustained intake of anti-malarial drug hyrdoxychloroquine (HCQ) along with appropriate use of personal protective equipment (PPE) led to a significant decline in the odds of healthcare workers getting infected with the coronavirus infection, a study has indicated.
-
Benefits Of Hydroxychroloquine Outweighs Its Risks: Niti Aayog Member
As per the current available data, benefits of anti-malarial drug Hydroxychroloquine (HCQ) "outweighs" the risks, if any, Niti Aayog member VK Paul said on Thursday, asserting it should be used as per guidelines and recommendations made by the scientific community.
-
France Bans Anti-Malarial Drug Hydroxychloroquine For COVID-19 Treatment
The French government on Wednesday banned treatment of COVID-19 patients with hydroxychloroquine, a controversial and potentially harmful drug that US President Donald Trump has said he is taking preventively.
-
WHO Stops Trial Of Anti-Malarial Drug For COVID-19 Over Safety Concerns
The World Health Organization said Monday it had temporarily suspended clinical trials of hydroxychloriquine as a potential treatment for COVID-19 being carried out across a range of countries as a precautionary measure.
-
Live Coronavirus Updates: WHO Stops Trial Of Anti-Malarial Drug For COVID-19
Delhi recorded 635 fresh cases of COVID-19 on Monday, taking the tally to 14,053 with 276 deaths so far in the national capital.
-
Top Medical Body ICMR Issues Revised Advisory On Use Of Anti-Malarial Drug Hydroxychloroquine
A revised government advisory has recommended use of hydroxychloroquine as a preventive medication for asymptomatic healthcare workers working in non-COVID-19 hospitals, frontline staff on surveillance duty in containment zones and paramilitary/police personnel involved in coronavirus infection related activities.
-
5 Hospitals Join Top Medical Body's Study On Anti-Malarial Drug
Five hospitals have enrolled so far for an observational study being conducted by ICMR to assess the efficacy of anti-malarial drug hydroxychloroquine as a preventive medication against COVID-19 among healthcare personnel.
-
Brazil Loses 2nd Health Minister In A Month Amid Chaotic Coronavirus Response
Brazil lost its second health minister in a month on Friday after President Jair Bolsonaro demanded wider use of unproven anti-malarial drugs to fight the coronavirus outbreak, adding to turmoil in one of the pandemic's worst global hotspots.
-
Over 1 Crore PPEs, 10 Crore Anti-Malarial Drug HCQ Distributed To States Free Of Cost: Government
Over 3.04 crore N95 masks, more than 1.28 crore PPE kits and over 10.83 crore HCQ tablets have been distributed among the states, union territories and central institutions, free of cost by the central government since March 11, said the Union Ministry of Health and Family Welfare on Thursday.
-
Centre Lifts Export Ban On Anti-Malarial Drug Hydroxychloroquine
The government on Thursday lifted the export ban on anti-malarial drug hydroxychloroquine with immediate effect.
-
Anti-Malarial Drug HCQ Does Not Reduce COVID-19 Mortality Rate, Says WHO, Halts Trial
The World Health Organization said it had decided Wednesday to halt trials of hydroxychloroquine as a potential treatment for COVID-19 patients, finding it did not reduce the mortality rate.
-
US Revokes Emergency Use Status Of Anti-Malarial Drug HCQ In COVID-19 Treatment
The United States on Monday withdrew emergency use authorizations for two coronavirus treatments favored by President Donald Trump, citing their lack of efficacy and safety concerns.
-
Health Ministry Okays Anti-Malarial Drug HCQ For Early Course Of COVID-19
The Union Health Ministry has recommended use of anti-viral drug remdesivir under emergency use authorization, off-label application of immunomodulator tocilizumab and convalescent plasma therapy for treating COVID-19 patients in moderate stage of criticality.
-
India Lifts Export Ban On Trump-Touted COVID-19 Drug Hydroxychloroquine
India has lifted an export ban on hydroxychloroquine, the anti-malarial drug touted by US President Donald Trump as a potential "game changer" in the fight against the COVID-19 pandemic, a minister said late on Wednesday.
-
Medical Journal Lancet Withdraws Study Flagging COVID-19 Drug's Risk
Three of the four authors behind a large-scale study in The Lancet that raised safety fears over the use of common anti-malarial drugs to treat COVID-19 retracted their paper on Thursday, blaming a health care company that supplied the dataset.
-
Anti-Malarial Drug, PPEs Prevented COVID-19 Among Health Workers: Report
Sustained intake of anti-malarial drug hyrdoxychloroquine (HCQ) along with appropriate use of personal protective equipment (PPE) led to a significant decline in the odds of healthcare workers getting infected with the coronavirus infection, a study has indicated.
-
Benefits Of Hydroxychroloquine Outweighs Its Risks: Niti Aayog Member
As per the current available data, benefits of anti-malarial drug Hydroxychroloquine (HCQ) "outweighs" the risks, if any, Niti Aayog member VK Paul said on Thursday, asserting it should be used as per guidelines and recommendations made by the scientific community.
-
France Bans Anti-Malarial Drug Hydroxychloroquine For COVID-19 Treatment
The French government on Wednesday banned treatment of COVID-19 patients with hydroxychloroquine, a controversial and potentially harmful drug that US President Donald Trump has said he is taking preventively.
-
WHO Stops Trial Of Anti-Malarial Drug For COVID-19 Over Safety Concerns
The World Health Organization said Monday it had temporarily suspended clinical trials of hydroxychloriquine as a potential treatment for COVID-19 being carried out across a range of countries as a precautionary measure.
-
Live Coronavirus Updates: WHO Stops Trial Of Anti-Malarial Drug For COVID-19
Delhi recorded 635 fresh cases of COVID-19 on Monday, taking the tally to 14,053 with 276 deaths so far in the national capital.
-
Top Medical Body ICMR Issues Revised Advisory On Use Of Anti-Malarial Drug Hydroxychloroquine
A revised government advisory has recommended use of hydroxychloroquine as a preventive medication for asymptomatic healthcare workers working in non-COVID-19 hospitals, frontline staff on surveillance duty in containment zones and paramilitary/police personnel involved in coronavirus infection related activities.
-
5 Hospitals Join Top Medical Body's Study On Anti-Malarial Drug
Five hospitals have enrolled so far for an observational study being conducted by ICMR to assess the efficacy of anti-malarial drug hydroxychloroquine as a preventive medication against COVID-19 among healthcare personnel.
-
Brazil Loses 2nd Health Minister In A Month Amid Chaotic Coronavirus Response
Brazil lost its second health minister in a month on Friday after President Jair Bolsonaro demanded wider use of unproven anti-malarial drugs to fight the coronavirus outbreak, adding to turmoil in one of the pandemic's worst global hotspots.
